![Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES - ScienceDirect Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S016836591930077X-ga1.jpg)
Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES - ScienceDirect
![Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM) - The Journal of Sexual Medicine Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM) - The Journal of Sexual Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/04f322d2-8e2a-4e26-9ddf-a98ef9d76434/gr1_lrg.jpg)
Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM) - The Journal of Sexual Medicine
![Controlled-release vaginal ring drug-delivery systems: a key strategy for the development of effective HIV microbicides | Therapeutic Delivery Controlled-release vaginal ring drug-delivery systems: a key strategy for the development of effective HIV microbicides | Therapeutic Delivery](https://www.future-science.com/cms/10.4155/tde.10.74/asset/images/medium/figure1.gif)